1-3 of 3
Amy S. Duffield
Close
Sort by
Journal Articles

Regression of smoldering myeloma with treatment of Gaucher disease

Kevin Barley, Anshuman Parekh, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukla, Deepa Vatti, Daniel Verina, Chanan Stauffer, Christian Salib, Siraj El Jamal, Julie Teruya-Feldstein, Amy S. Duffield, Violetta V. Leshchenko, Sundar Jagannath, Manisha Balwani, Samir Parekh
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1634–1638.
https://doi.org/10.1182/bloodadvances.2023012304
Published: 2024
Includes: Supplemental data
Journal Articles

Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis

David J. Young, Bao Nguyen, Ruiqi Zhu, Jaesung Seo, Li Li, Mark J. Levis, Keith W. Pratz, Amy S. Duffield, Donald Small
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2285–2293.
https://doi.org/10.1182/bloodadvances.2020002876
Published: 2021
Includes: Supplemental data
Journal Articles

Th17 immune microenvironment in Epstein-Barr virus–negative Hodgkin lymphoma: implications for immunotherapy

Clinical Trials & Observations
Amy S. Duffield, Maria Libera Ascierto, Robert A. Anders, Janis M. Taube, Alan K. Meeker, Shuming Chen, Tracee L. McMiller, Neil A. Phillips, Haiying Xu, Aleksandra Ogurtsova, Alan E. Berger, Drew M. Pardoll, Suzanne L. Topalian, Richard F. Ambinder
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1324–1334.
https://doi.org/10.1182/bloodadvances.2017007260
Published: 2017
Includes: Supplemental data